Results showed that combination therapy could inhibited tumor growth by transforming tumor with low immunoreactivity into inflamed (‘hot’) tumor, as demonstrated by increased CD8+granzyme B+ cytotoxic T cell infiltration. The gene discussed is GZMB; the disease is neoplasm.